Clinical and Near Clinical Projects
Advaxis is developing multiple platform approaches to the treatment of several cancers included in the chart below which represent a market potential in excess of $10 billion.
In Early Development
Vaccines in early development include treatments for other cancers, including:
Ovarian, Glioma, lymphomas, leukemias, angiogenesis inhibitors and others.
